Who can participate in the SONOBIRD trial ?
This trial is open to adult patients at first recurrence of glioblastoma after initial therapy, to whom doctors recommend a new partial or total tumor resection and chemotherapy.
This trial is proposed to adult patients at first recurrence of glioblastoma to whom doctors recommend a new tumor resection and chemotherapy.
Eligible patients should also:
- present with a tumor maximum size of 5 centimeters in diameter
- be recovered from side effects of all prior anticancer therapy
- not have any other serious medical or psychological condition that may hamper safe delivery of treatment and care
Those are main criteria. The neurooncologists and neurosurgeons involved in the trial will also assess patients’ prior and ongoing treatments, tumor characteristics as well as disease and global health status.
Visit our page on the investigational sites to learn about participating healthcare facilities.
More details on the inclusion and non-inclusion criteria can be found on clinicaltrials.gov.